Cytiva is pioneering an innovative recyclable packaging solution to replace polystyrene through its Designing in Sustainability strategy. In collaboration with TemperPack, a leading provider of cold chain packaging, new liners are made with renewable paper and corn starch as their primary ingredients. The insulation is proven to maintain the necessary low temperatures in shipping boxes and greatly reduce the amount of waste Cytiva’s customers send to landfill.
Emmanuel Abate, President of Genomic Medicine and Head of Sustainability, says: “We’re delighted to support our customers’ ambitions to prioritize sustainability. Our new packaging and distribution method will prevent the equivalent of 71 shipping containers filled with polystyrene from ending up in landfills. And we couldn’t have done it without the excellent collaboration of TemperPack.”
Replacing polystyrene is a key part of Cytiva’s ambitious sustainability targets. Each year Cytiva ships approximately 60,000 polystyrene boxes of product used to make life-saving vaccines and therapeutics. Those products require protection and temperature control which until now, was done best with polystyrene. Once this new packaging solution is deployed globally, 2335 cubic meters of waste will be eliminated (the equivalent of 71 ocean shipping containers). By 2025 polystyrene will be completely eliminated from Cytiva packaging.
Brianna Mackay, Director of Sales, TemperPack, says: “TemperPack’s mission is to develop sustainable packaging materials to replace plastic, at scale. It’s great to align with Cytiva who shares our values and our ambitious sustainability goals.”
Abate says: “Sustainability is the engine behind our innovation here. We’re pleased to be out in front, leading this important change. I encourage the entire life sciences industry to consider changing how we deliver our products.”
B-roll is available upon request.
About Cytiva
At Cytiva, we believe the key to transforming human health is accessing life-changing therapies. That’s why our nearly 10 000 associates in more than 40 countries are keenly focused on helping researchers, biopharma companies, and drug manufacturers to advance and accelerate therapeutics for people that need them. We’re driven by their desire to achieve better flexibility, capacity, and efficiency in all facets of their work – all the way from discovery to delivery. Learn more at cytiva.com.
Media contact:
Colleen Connolly
[email protected]
+1 774 245 3893